Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 2 | Future Journal of Pharmaceutical Sciences

Fig. 2

From: Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway

Fig. 2

The combined cell viability activity of α + β-asarone (0.61 mM + 0.73 mM) was more effective than the single entity of either α- or β-asarone (0.61 mM or 0.73 mM) when compared to the untreated (UT) group. Values represent mean ± SEM of an experiment done in triplicate; one-way ANOVA followed by Bonferroni test, where *p < 0.05, **p < 0.01, and ***p < 0.001 when compared as indicated

Back to article page